Dna X (SONM) Invested Capital (2018 - 2025)
Dna X (SONM) has disclosed Invested Capital for 8 consecutive years, with -$701000.0 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Invested Capital fell 104.57% year-over-year to -$701000.0, compared with a TTM value of -$701000.0 through Sep 2025, down 104.57%, and an annual FY2024 reading of -$5.7 million, down 125.48% over the prior year.
- Invested Capital was -$701000.0 for Q3 2025 at Dna X, up from -$1.3 million in the prior quarter.
- Across five years, Invested Capital topped out at $23.1 million in Q3 2023 and bottomed at -$5.7 million in Q4 2024.
- Average Invested Capital over 5 years is $13.5 million, with a median of $17.5 million recorded in 2024.
- The sharpest move saw Invested Capital soared 203.69% in 2023, then crashed 125.48% in 2024.
- Year by year, Invested Capital stood at $18.8 million in 2021, then rose by 7.53% to $20.2 million in 2022, then increased by 10.78% to $22.4 million in 2023, then plummeted by 125.48% to -$5.7 million in 2024, then soared by 87.7% to -$701000.0 in 2025.
- Business Quant data shows Invested Capital for SONM at -$701000.0 in Q3 2025, -$1.3 million in Q2 2025, and -$1.1 million in Q1 2025.